Researchers at the University of Glasgow have developed a new weapon in humanity’s ongoing war against cancer.
As the world’s aging population grows, a new host of tools designed for the dying has emerged.
Thirteen years, three billion dollars. That’s the size of the investment made to map the human genome in its entirety, give or take a few months and a few million. While scientists completed the effort over a decade ago, we’re only starting to reap the returns.